EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS109-05805 
Organism
Homo sapiens 
Tissue/cell
Kasumi-1 
Coordinate
chr12:94567990-94569030 
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ELK1MA0028.2chr12:94568497-94568507ACCGGAAGTG+6.02
ELK4MA0076.2chr12:94568497-94568508ACCGGAAGTGG-6.32
ERGMA0474.2chr12:94568497-94568507ACCGGAAGTG+6.02
ETS1MA0098.3chr12:94568497-94568507ACCGGAAGTG+6.02
FEVMA0156.2chr12:94568497-94568507ACCGGAAGTG+6.02
FLI1MA0475.2chr12:94568497-94568507ACCGGAAGTG+6.02
GFI1MA0038.2chr12:94568275-94568287CAAATCACAGCA+6.52
Gfi1bMA0483.1chr12:94568276-94568287AAATCACAGCA+6.62
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_43721chr12:94562891-94570566MM1S
SE_60822chr12:94541111-94570631DHL6
SE_67301chr12:94562891-94570566MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr129456837394568733
Number: 1             
IDChromosomeStartEnd
GH12I094171chr129456532394570387
Enhancer Sequence
GGCTCTGTTG CCCAGGCTGG AGTGCAGTGG TGCAGTCTCG GCTCACTACA ACCTCTGTCT 60
CCCAGGCTTA AGCGATCCTC CCACCTCAGC CTCTTGAGTA GCTGGGACTA CAGACCTGTG 120
CCCCCACACC TGGCTAATTT TTTTGTATGG ACAGGGTTTT GCCATGTTGC CCAGGCTGGT 180
CTCAAACTCC TAGGCTCAAG AGATCCTCCC ACCTCGGCCT TCCAAAGAGC TGGGATTACA 240
GGCATGAGCC ACTGCACACG GCGCCACTCA GGGATTTCGT TTATTCAAAT CACAGCAAAA 300
TTAAACCGGT TCCAAAAAGT TCTGTCTGAA TTCAAACAGA AGCAAAAACT CTGTACTGCC 360
TAAAGAGTCT GCCTTGACTC TGGTTATTGA AGTTTTTGAA TGAATGTCAG AGAAAAAAAT 420
CTTTTGTAAA GGCAAGCTGT ACTATATACC CAGAAGATGT TCAAATAAGG AATAGGAGAA 480
CTTGGGGAAC CTAGAACAGG ACCTGGGACC GGAAGTGGTG GTGGTGGTGG GGATGACTGA 540
GCTAACAGAC CAAAAAGTTA AAACAGGAGG AAGTGTCAAA ACTTGGAAGT GGGTTCATTG 600
GTTGGCTGTT TAGGATGTCA TGTGAAGCCT GCTTCAAGTT CTCCCCACCT CATTAATTGC 660
AATTTATGAG TTTGCAGGGA CTCCCCAGTT TGAAACTTTT AGTCCCATAT AATCCACAAA 720
TCTAGAACCT GTGGTTCAGA CTGTATGCTT CTCTTACTAC CTACACTGCA ATAAGTAGAT 780
TGGAAACAAA AGAGAAATTT GCCTTGATCT TTATATTTCA TCTTTGTTAC TCCTAACTAC 840
TGAGGCACAT TAAATACTTA CCTTGCTTTC TCCTGTGTGT GCATGTGTGT GTGTGTGCAC 900
GCATGCACAG GCATGCACGT GTGTGTATAT GTATGCAGGC ATGCACGTGC ATATGTGTGT 960
GTGAGCTTGT GTGTGTGTAT GTGTGGTTTA AGTCTCCTTC CCAGCATTTC TCAGAAACTG 1020
CTTATGGAAA AAAATAATAA 1040